- Home
- IVVD vs OPFI Comparison
IVVD vs OPFI Comparison
Compare IVVD & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- OPFI
- Stock Information
- Founded
- IVVD 2020
- OPFI 2009
- Country
- IVVD United States
- OPFI United States
- Employees
- IVVD N/A
- OPFI N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- OPFI Finance: Consumer Services
- Sector
- IVVD Health Care
- OPFI Finance
- Exchange
- IVVD Nasdaq
- OPFI Nasdaq
- Market Cap
- IVVD 351.6M
- OPFI 343.1M
- IPO Year
- IVVD 2021
- OPFI N/A
- Fundamental
- Price
- IVVD $1.75
- OPFI $9.46
- Analyst Decision
- IVVD Strong Buy
- OPFI Buy
- Analyst Count
- IVVD 5
- OPFI 2
- Target Price
- IVVD $5.11
- OPFI $11.75
- AVG Volume (30 Days)
- IVVD 5.6M
- OPFI 916.9K
- Earning Date
- IVVD 11-13-2025
- OPFI 10-29-2025
- Dividend Yield
- IVVD N/A
- OPFI 10.47%
- EPS Growth
- IVVD N/A
- OPFI N/A
- EPS
- IVVD N/A
- OPFI N/A
- Revenue
- IVVD $46,210,000.00
- OPFI $320,831,000.00
- Revenue This Year
- IVVD $112.35
- OPFI $118.17
- Revenue Next Year
- IVVD $272.14
- OPFI $11.29
- P/E Ratio
- IVVD N/A
- OPFI N/A
- Revenue Growth
- IVVD 1941.08
- OPFI 31.26
- 52 Week Low
- IVVD $0.35
- OPFI $4.78
- 52 Week High
- IVVD $2.74
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- IVVD 64.77
- OPFI 35.27
- Support Level
- IVVD $1.56
- OPFI $9.71
- Resistance Level
- IVVD $2.01
- OPFI $10.45
- Average True Range (ATR)
- IVVD 0.19
- OPFI 0.49
- MACD
- IVVD 0.03
- OPFI -0.16
- Stochastic Oscillator
- IVVD 72.92
- OPFI 1.91
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.